跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Elmox-CV 457 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Elmox-CV 457
Approved
STANDARD
Elmox-CV 457
Yeluri Formulations Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
afa0a49744c013b9
Company
Yeluri Formulations Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
afa0a49744c013b9
Drug Approval Philippines Name
Elmox-CV 457
Product Name
Elmox-CV 457
Registration Number
DRP-12194
Brand Name
Elmox-CV 457
Generic Name
Co-Amoxiclav
Dosage Form
Powder for Oral Suspension
Dosage Strength
457 mg/5 mL
Manufacturer
Yeluri Formulations Pvt. Ltd.
Importer
Pharma-Surrey International, Inc.
Distributor
Pharma-Surrey International, Inc.
Issuance Date
28 June 2022
Expiry Date
28 June 2027
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
afa0a49744c013b9
Type
Standard
Back to Philippines FDA Approvals